Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
J. Bitzer, A. Rapkin & C. N. Soares. (2018) Managing the risks of mood symptoms with LNG-IUS: a clinical perspective. The European Journal of Contraception & Reproductive Health Care 23:5, pages 321-325.
Read now
Read now
Jonathan Schaffir, Brett L. Worly & Tamar L. Gur. (2016) Combined hormonal contraception and its effects on mood: a critical review. The European Journal of Contraception & Reproductive Health Care 21:5, pages 347-355.
Read now
Read now
Anita L Nelson. (2011) What women want from their oral contraceptives. Expert Review of Obstetrics & Gynecology 6:5, pages 509-523.
Read now
Read now
H. T. Kränzlin & M. A. Nap. (2006) The effect of a phasic oral contraceptive containing Desogestrel on seborrhea and acne. The European Journal of Contraception & Reproductive Health Care 11:1, pages 6-13.
Read now
Read now
Articles from other publishers (28)
Margot W.L. Morssinkhof, Femke Lamers, Adriaan W. Hoogendoorn, Anouk E. de Wit, Harriëtte Riese, Erik J. Giltay, Odile A. van den Heuvel, Brenda W. Penninx & Birit F.P. Broekman. (2021) Oral contraceptives, depressive and insomnia symptoms in adult women with and without depression. Psychoneuroendocrinology 133, pages 105390.
Crossref
Crossref
Mashael Alfaifi, AliH Najmi, KhadijaH Swadi, AbdullahA Almushtawi & SattamA Jaddoh. (2021) Prevalence of contraceptive use and its association with depression among women in the Jazan province of Saudi Arabia. Journal of Family Medicine and Primary Care 10:7, pages 2503.
Crossref
Crossref
Inger Sundström-Poromaa. 2021. Female and Male Contraception. Female and Male Contraception
45
56
.
Tenille C. Taggart, Nicholas R. Eaton, Katherine M. Keyes, Julia F. Hammett & Emilio C. Ulloa. (2018) Oral contraceptive use is associated with greater mood stability and higher relationship satisfaction. Neurology, Psychiatry and Brain Research 30, pages 154-162.
Crossref
Crossref
Megumi Horibe, Yuuki Hane, Junko Abe, Toshinobu Matsui, Yamato Kato, Natsumi Ueda, Sayaka Sasaoka, Yumi Motooka, Haruna Hatahira, Shiori Hasegawa, Yasutomi Kinosada, Hideaki Hara & Mitsuhiro Nakamura. (2018) Contraceptives as possible risk factors for postpartum depression: A retrospective study of the food and drug administration adverse event reporting system, 2004-2015. Nursing Open 5:2, pages 131-138.
Crossref
Crossref
Diana Armbruster, Clemens Kirschbaum & Alexander Strobel. (2017) The not-so-bitter pill: Effects of combined oral contraceptives on peripheral physiological indicators of emotional reactivity. Hormones and Behavior 94, pages 97-105.
Crossref
Crossref
Niklas Zethraeus, Anna Dreber, Eva Ranehill, Liselott Blomberg, Fernand Labrie, Bo von Schoultz, Magnus Johannesson & Angelica Lindén Hirschberg. (2017) A first-choice combined oral contraceptive influences general well-being in healthy women: a double-blind, randomized, placebo-controlled trial. Fertility and Sterility 107:5, pages 1238-1245.
Crossref
Crossref
Sarah Johnson, Christine Pion & Victoria Jennings. (2013) Current methods and attitudes of women towards contraception in Europe and America. Reproductive Health 10:1.
Crossref
Crossref
K. M. Keyes, K. Cheslack-Postava, C. Westhoff, C. M. Heim, M. Haloossim, K. Walsh & K. Koenen. (2013) Association of Hormonal Contraceptive Use With Reduced Levels of Depressive Symptoms: A National Study of Sexually Active Women in the United States. American Journal of Epidemiology 178:9, pages 1378-1388.
Crossref
Crossref
Lisa L. M. Welling. (2013) Psychobehavioral Effects of Hormonal Contraceptive Use. Evolutionary Psychology 11:3, pages 147470491301100.
Crossref
Crossref
Malin Gingnell, Jonas Engman, Andreas Frick, Lena Moby, Johan Wikström, Mats Fredrikson & Inger Sundström-Poromaa. (2013) Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill—A double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive. Psychoneuroendocrinology 38:7, pages 1133-1144.
Crossref
Crossref
E. Anne MacGregor. (2013) Contraception and Headache. Headache: The Journal of Head and Face Pain 53:2, pages 247-276.
Crossref
Crossref
N. Cinar, A. Harmanci, B. Demir & B. O. Yildiz. (2012) Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study. Human Reproduction 27:6, pages 1840-1845.
Crossref
Crossref
INGER SUNDSTRÖM POROMAA & BIRGITTA SEGEBLADH. (2012) Adverse mood symptoms with oral contraceptives. Acta Obstetricia et Gynecologica Scandinavica 91:4, pages 420-427.
Crossref
Crossref
E. Anne MacGregor & Astrid Gendolla. 2011. Handbook of Headache. Handbook of Headache
619
635
.
Belgin Akın, Emel Ege, Nihayet Aksüllü, Nesime Demirören & Hatice Erdem. (2010) Combined Oral Contraceptives Use and Relationship with Depressive Symptoms in Turkey. Sexuality and Disability 28:4, pages 265-273.
Crossref
Crossref
Rogério Bonassi Machado, Alice Pinheiro Pereira, Geórgia Perez Coelho, Larissa Neri, Larissa Martins & Daniele Luminoso. (2010) Epidemiological and clinical aspects of migraine in users of combined oral contraceptives. Contraception 81:3, pages 202-208.
Crossref
Crossref
Jinna Zhao, Ying Li, Yulin Wu, Jian Zhou, Lei Ba, Xiaoping Gu, Weidong Wang, Hui Yao, Naixiu Ren, Jianhong Chen & Lianfang Xu. (2009) Impact of different contraceptive methods on quality of life in rural women of the Jiangsu province in China. Contraception 80:2, pages 180-186.
Crossref
Crossref
Birgitta Segebladh, Anna Borgström, Viveca Odlind, Marie Bixo & Inger Sundström-Poromaa. (2009) Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives. Contraception 79:1, pages 50-55.
Crossref
Crossref
Anna Borgström, Viveca Odlind, Lisa Ekselius & Inger Sundström-Poromaa. (2008) Adverse mood effects of combined oral contraceptives in relation to personality traits. European Journal of Obstetrics & Gynecology and Reproductive Biology 141:2, pages 127-130.
Crossref
Crossref
Abbey B. Berenson, Susan D. Odom, Carmen Radecki Breitkopf & Mahbubur Rahman. (2008) Physiologic and psychologic symptoms associated with use of injectable contraception and 20 μg oral contraceptive pills. American Journal of Obstetrics and Gynecology 199:4, pages 351.e1-351.e12.
Crossref
Crossref
Anna Borgström, Kristiina Kask, Maria Gulinello, Viveca Odlind & Inger Sundström-Poromaa. (2008) Patients with adverse mood effects from combined oral contraceptives have lower levels of prepulse inhibition than healthy controls. Psychoneuroendocrinology 33:4, pages 487-496.
Crossref
Crossref
E Anne MacGregor. (2007) Migraine and use of combined hormonal contraceptives: a clinical review. Journal of Family Planning and Reproductive Health Care 33:3, pages 159-169.
Crossref
Crossref
N. Kurshan & C. Neill Epperson. (2005) Oral contraceptives and mood in women with and without premenstrual dysphoria: a theoretical model. Archives of Women's Mental Health 9:1, pages 1-14.
Crossref
Crossref
Elizabeth W. Loder, Dawn C. Buse & Joan R. Golub. (2005) Headache as a side effect of combination estrogen-progestin oral contraceptives: A systematic review. American Journal of Obstetrics and Gynecology 193:3, pages 636-649.
Crossref
Crossref
Virginia J. Vitzthum & Karin Ringheim. (2005) Hormonal Contraception and Physiology: A Research‐based Theory of Discontinuation Due to Side Effects. Studies in Family Planning 36:1, pages 13-32.
Crossref
Crossref
U.H. Winkler, H. Ferguson & J.A.P.A. Mulders. (2004) Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 μg ethinylestradiol. Contraception 69:6, pages 469-476.
Crossref
Crossref
J Callejo, J Díaz, A Ruiz & R.M García. (2003) Effect of a low-dose oral contraceptive containing 20 μg ethinylestradiol and 150 μg desogestrel on dysmenorrhea. Contraception 68:3, pages 183-188.
Crossref
Crossref